Today is World Atopic Eczema Day, established to enhance awareness, understanding and management of a skin condition that can severely affect patients’ health and wellbeing.
Momentum continues to build in the use of high-efficacy, disease modifying therapies (DMTs) as a first choice for treating multiple sclerosis. How is this being influenced by the availability of anti-CD20s, a new class of DMT? Will future new therapy classes change the paradigm even further?
The COVID-19 pandemic has been challenging for healthcare systems worldwide – with an already overburdened system and large population, the Indian healthcare system was no exception.
Ipsos partnered with the HLTH Foundation to shine a light on existing health tech-related inequities in the US and identify opportunities for the industry to address techquity gaps.
How have the Point of Care (PoC) and rapid testing markets evolved over the past two years? What are the key challenges, unmet needs and opportunities for companies working in POC & rapid testing today?
